Jack Elands is the founder of Adcytherix. Adcytherix has raised $144M in total funding. Latest round: Series A. Based in Marseille, France.
Jack Elands is the founder and CEO of Adcytherix, a biopharmaceutical company founded in 2024 that develops next-generation antibody-drug conjugates for cancer treatment. He previously co-founded Emergence Therapeutics. Under his leadership, Adcytherix secured €30 million in seed funding in June 2024 and a record €105 million Series A in 2025.
Full founder directory · Investor directory · Company funding database · Fundraising library